Latest stories on CAMP
CAMP4 Moves Into Human Trials -- The Upside Is Underpriced
Seeking Alpha73 · bullishproduct/pr
CAMP4’s CMP-002 Trial Gets Green Light in Australia, Unlocking $50 Million for SYNGAP1 Disorder Research
July 27, 2026
MarketChameleon73 · bullishproduct/pr
Camp4 Therapeutics Corp (CAMP) files 8-K
SEC 8-K50 · neutralgeneral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | CAMP Stock News
StockTitan50 · neutralgeneral
Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones?
Yahoo Finance63 · neutralanalyst
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CAMP Stock News
StockTitan50 · neutralgeneral
Camp4 Therapeutics Corp (CAMP) files 8-K
SEC 8-K50 · neutralgeneral
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | CAMP Stock News
StockTitan50 · neutralgeneral